CD8A and neoplasm: Concurrently, the “SUP3 + anti-PD-L1 + Flt3L” treatment also increased the frequency of IFN-γ+ CD8+ T cells in the B16F10 tumor model compared to the PAM3-based triple combination (Fig. 7J and Supplementary Fig S9C).